BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 14701824)

  • 1. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter.
    Haidar B; Denis M; Marcil M; Krimbou L; Genest J
    J Biol Chem; 2004 Mar; 279(11):9963-9. PubMed ID: 14701824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts.
    Haidar B; Denis M; Krimbou L; Marcil M; Genest J
    J Lipid Res; 2002 Dec; 43(12):2087-94. PubMed ID: 12454270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol.
    Tang C; Vaughan AM; Oram JF
    J Biol Chem; 2004 Feb; 279(9):7622-8. PubMed ID: 14668333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo.
    Chroni A; Liu T; Gorshkova I; Kan HY; Uehara Y; Von Eckardstein A; Zannis VI
    J Biol Chem; 2003 Feb; 278(9):6719-30. PubMed ID: 12488454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1).
    Denis M; Haidar B; Marcil M; Bouvier M; Krimbou L; Genest J
    J Biol Chem; 2004 Feb; 279(9):7384-94. PubMed ID: 14660648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-4F, an apolipoprotein A-I mimetic peptide, promotes cholesterol efflux from macrophages via ATP-binding cassette transporter A1.
    Xie Q; Zhao SP; Li F
    Tohoku J Exp Med; 2010 Mar; 220(3):223-8. PubMed ID: 20208418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly.
    Yamauchi Y; Hayashi M; Abe-Dohmae S; Yokoyama S
    J Biol Chem; 2003 Nov; 278(48):47890-7. PubMed ID: 12952980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via the ATP-binding cassette transporter ABCA1.
    Panagotopulos SE; Witting SR; Horace EM; Hui DY; Maiorano JN; Davidson WS
    J Biol Chem; 2002 Oct; 277(42):39477-84. PubMed ID: 12181325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol.
    Oram JF; Vaughan AM; Stocker R
    J Biol Chem; 2001 Oct; 276(43):39898-902. PubMed ID: 11546785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter.
    Chambenoit O; Hamon Y; Marguet D; Rigneault H; Rosseneu M; Chimini G
    J Biol Chem; 2001 Mar; 276(13):9955-60. PubMed ID: 11150301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1.
    Witting SR; Maiorano JN; Davidson WS
    J Biol Chem; 2003 Oct; 278(41):40121-7. PubMed ID: 12890677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-I activates Cdc42 signaling through the ABCA1 transporter.
    Nofer JR; Remaley AT; Feuerborn R; Wolinnska I; Engel T; von Eckardstein A; Assmann G
    J Lipid Res; 2006 Apr; 47(4):794-803. PubMed ID: 16443932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium taurocholate-dependent lipid efflux by ABCA1: effects of W590S mutation on lipid translocation and apolipoprotein A-I dissociation.
    Nagao K; Zhao Y; Takahashi K; Kimura Y; Ueda K
    J Lipid Res; 2009 Jun; 50(6):1165-72. PubMed ID: 19202195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
    Neufeld EB; Stonik JA; Demosky SJ; Knapper CL; Combs CA; Cooney A; Comly M; Dwyer N; Blanchette-Mackie J; Remaley AT; Santamarina-Fojo S; Brewer HB
    J Biol Chem; 2004 Apr; 279(15):15571-8. PubMed ID: 14747463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis.
    Hassan HH; Denis M; Lee DY; Iatan I; Nyholt D; Ruel I; Krimbou L; Genest J
    J Lipid Res; 2007 Nov; 48(11):2428-42. PubMed ID: 17656736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of ABCA1-dependent compartmentalization and trafficking of apolipoprotein A-I: implications for determining cellular kinetics of nascent high density lipoprotein biogenesis.
    Hassan HH; Bailey D; Lee DY; Iatan I; Hafiane A; Ruel I; Krimbou L; Genest J
    J Biol Chem; 2008 Apr; 283(17):11164-75. PubMed ID: 18218626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein A-I increases insulin secretion and production from pancreatic β-cells via a G-protein-cAMP-PKA-FoxO1-dependent mechanism.
    Cochran BJ; Bisoendial RJ; Hou L; Glaros EN; Rossy J; Thomas SR; Barter PJ; Rye KA
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2261-7. PubMed ID: 25147338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced apoA-I-dependent cholesterol efflux by ABCA1 from sphingomyelin-deficient Chinese hamster ovary cells.
    Nagao K; Takahashi K; Hanada K; Kioka N; Matsuo M; Ueda K
    J Biol Chem; 2007 May; 282(20):14868-74. PubMed ID: 17409096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The establishment of telomerase-immortalized Tangier disease cell lines indicates the existence of an apolipoprotein A-I-inducible but ABCA1-independent cholesterol efflux pathway.
    Walter M; Forsyth NR; Wright WE; Shay JW; Roth MG
    J Biol Chem; 2004 May; 279(20):20866-73. PubMed ID: 15001567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease.
    Choi HY; Karten B; Chan T; Vance JE; Greer WL; Heidenreich RA; Garver WS; Francis GA
    J Biol Chem; 2003 Aug; 278(35):32569-77. PubMed ID: 12813037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.